GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Intangible Assets

Fonar (FONR) Intangible Assets : $7.5 Mil (As of Dec. 2023)


View and export this data going back to 1981. Start your Free Trial

What is Fonar Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Fonar's intangible assets for the quarter that ended in Dec. 2023 was $7.5 Mil.


Fonar Intangible Assets Historical Data

The historical data trend for Fonar's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Intangible Assets Chart

Fonar Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.74 8.10 8.31 7.97 7.70

Fonar Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.85 7.76 7.70 7.62 7.54

Fonar Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Fonar  (NAS:FONR) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Fonar Intangible Assets Related Terms

Thank you for viewing the detailed overview of Fonar's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar (FONR) Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022